Insider Trading & Ownership - Lipocine Inc. (LPCN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lipocine Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-25
Purchase
2023-05-25
3:10 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
8,706$5.03$43,791107,418
(Direct)
View
2023-03-24
Purchase
2023-03-24
5:28 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
150,000$0.32$48,0001,678,090
(Direct)
View
2023-03-20
Purchase
2023-03-20
6:51 pm
Lipocine Inc.LPCNOno Richard Dana
Director
4,000$0.34$1,36014,125
(Direct)
View
2023-03-17
Purchase
2023-03-17
4:31 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
50,000$0.33$16,5001,528,090
(Direct)
View
2022-11-22
Purchase
2022-11-28
4:33 pm
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
21,739$0.47$10,21721,739
(Direct)
View
2022-11-14
Purchase
2022-11-14
3:58 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
75,000$0.39$29,2501,478,090
(Direct)
View
2022-09-27
Purchase
2022-09-27
6:53 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
100,000$0.41$41,0001,403,090
(Direct)
View
2022-05-17
Purchase
2022-05-17
4:58 pm
Lipocine Inc.LPCNFogarty Krista
Principal Accounting Officer
12,500$0.86$10,75012,500
(Direct)
View
2022-05-16
Purchase
2022-05-16
6:44 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
50,000$0.7699$38,4951,303,090
(Direct)
View
2021-11-18
Purchase
2021-11-18
7:23 pm
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
25,000$1.09$27,2501,253,090
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-05
Option Award
2024-06-07
5:48 pm
2025-06-05
2034-06-05
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
1,764$7.055,410
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:45 pm
2025-06-05
2035-06-05
Lipocine Inc.LPCNOno Richard Dana
Director
1,764$7.0510,938
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:43 pm
2025-06-05
2034-06-05
Lipocine Inc.LPCNJene Jill M.
Director
1,764$7.055,410
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:41 pm
2025-06-05
2034-06-05
Lipocine Inc.LPCNHiguchi John W.
Director
1,764$7.0510,938
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:39 pm
2025-06-05
2034-06-05
Lipocine Inc.LPCNFink Jeffrey Arvin
Director
1,764$7.0510,938
(Direct)
View
2024-03-08
Option Award
2024-03-12
5:53 pm
N/A
N/A
Lipocine Inc.LPCNPatel Mahesh V.
CEO and President
4,893$0112,311
(Direct)
View
2024-03-08
Option Award
2024-03-12
5:51 pm
N/A
N/A
Lipocine Inc.LPCNFogarty Krista
Principal Accounting Officer
991$01,727
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:37 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
30,000$0.265662,000
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:36 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNHiguchi John W.
Director
30,000$0.2656156,000
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:35 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNOno Richard Dana
Director
30,000$0.2656166,000
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:34 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNJene Jill M.
Director
30,000$0.265662,000
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:33 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNFink Jeffrey Arvin
Director
30,000$0.2656166,000
(Direct)
View
2023-01-03
Option Award
2023-01-04
12:06 pm
2024-01-03
2033-01-03
Lipocine Inc.LPCNPatel Mahesh V.
Chief Executive Officer
300,000$0.412,542,395
(Direct)
View
2022-12-22
Option Award
2022-12-22
7:20 pm
2023-12-22
2032-12-22
Lipocine Inc.LPCNPatel Mahesh V.
Chief Executive Officer
112,500$0.412,242,395
(Direct)
View
2022-12-22
Option Award
2022-12-22
7:18 pm
2023-12-22
2032-12-22
Lipocine Inc.LPCNFogarty Krista
Principal Accounting Officer
91,850$0.41229,850
(Direct)
View
2022-11-01
Option Award
2022-11-08
11:57 am
2023-11-01
2032-11-01
Lipocine Inc.LPCNNomikos George
Chief Medical Officer
125,000$0.406125,000
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:36 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNOno Richard Dana
Director
22,000$0.92136,000
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:35 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNHiguchi John W.
Director
22,000$0.92307,490
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:34 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
22,000$0.9232,000
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:33 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNFink Jeffrey Arvin
Director
22,000$0.92136,000
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:32 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNJene Jill M.
Director
22,000$0.9232,000
(Direct)
View
2022-04-11
Option Award
2022-04-12
5:00 pm
2023-04-11
2032-04-11
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
10,000$1.1610,000
(Direct)
View
2022-04-11
Option Award
2022-04-12
4:57 pm
2023-04-11
2032-04-11
Lipocine Inc.LPCNJene Jill M.
Director
10,000$1.1610,000
(Direct)
View

Ownership
2022-01-27
09:15 am
2022-12-07
2031-12-07
Lipocine Inc.LPCNFogarty Krista
Principal Accounting Officer
0$0138,000
(Direct)
View
2022-01-03
Option Award
2022-01-03
5:33 pm
2023-01-03
2032-01-03
Lipocine Inc.LPCNPatel Mahesh V.
Chief Executive Officer
287,500$1.09287,500
(Direct)
View
2021-12-07
Option Award
2021-12-08
4:00 pm
2022-12-07
2031-12-07
Lipocine Inc.LPCNPatel Mahesh V.
Chief Executive Officer
125,000$1.12125,000
(Direct)
View
2021-12-07
Option Award
2021-12-08
4:00 pm
2022-12-07
2031-12-07
Lipocine Inc.LPCNBROWN MORGAN R
Chief Financial Officer
176,000$1.12176,000
(Direct)
View
Goto 0, 1, Next